Plan B : Is Behind-The-Counter Around The Corner?
This article was originally published in The Tan Sheet
Executive Summary
If Barr Labs and FDA find common ground in developing a behind-the-pharmacy-counter sales scheme for emergency contraceptive Plan B, they could pave the way for future complex Rx-to-OTC switches
You may also be interested in...
Von Eschenbach Nomination Criticized By Conservatives Over Plan B Switch
The nomination of Andrew von Eschenbach to FDA full commissioner is now being challenged by conservatives, in reaction to the agency's reconsideration of Barr Labs' switch application for emergency contraceptive Plan B
Von Eschenbach Nomination Criticized By Conservatives Over Plan B Switch
The nomination of Andrew von Eschenbach to FDA full commissioner is now being challenged by conservatives, in reaction to the agency's reconsideration of Barr Labs' switch application for emergency contraceptive Plan B
Von Eschenbach Nomination Criticized By Conservatives Over Plan B Switch
The nomination of Andrew von Eschenbach to FDA full commissioner is now being challenged by conservatives, in reaction to the agency's reconsideration of Barr Labs' switch application for emergency contraceptive Plan B